Price target
62.870.000.00%
The 8 analysts offering 1 year price forecasts for RV7 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 9 analysts giving stock ratings to RV7 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RV7 EPS for the last quarter is 1.14 EUR despite the estimation of 0.89 EUR. In the next quarter EPS is expected to reach 1.12 EUR. Track more of HALOZYME THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter HALOZYME THERAPEUTICS INC revenue is expected to reach 278.57 M EUR. Check out HALOZYME THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, RV7 price target is 62.87 EUR with a max estimate of 74.76 EUR and a min estimate of 51.46 EUR. Check if this forecast comes true in a year, meanwhile watch HALOZYME THERAPEUTICS INC stock price chart and keep track of the current situation with RV7 news and stock market news.
We've gathered opinions of 9 analysts rating RV7 stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.